OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The dawn of a new era of targeted lipid-lowering therapies
Lâle Tokgözoğlu, Peter Libby
European Heart Journal (2021) Vol. 43, Iss. 34, pp. 3198-3208
Open Access | Times Cited: 111
Lâle Tokgözoğlu, Peter Libby
European Heart Journal (2021) Vol. 43, Iss. 34, pp. 3198-3208
Open Access | Times Cited: 111
Showing 1-25 of 111 citing articles:
2024 ESC Guidelines for the management of chronic coronary syndromes
Christiaan Vrints, Felicita Andreotti, Konstantinos C. Koskinas, et al.
European Heart Journal (2024) Vol. 45, Iss. 36, pp. 3415-3537
Open Access | Times Cited: 525
Christiaan Vrints, Felicita Andreotti, Konstantinos C. Koskinas, et al.
European Heart Journal (2024) Vol. 45, Iss. 36, pp. 3415-3537
Open Access | Times Cited: 525
Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials
Paul M. Ridker, Deepak L. Bhatt, Aruna D. Pradhan, et al.
The Lancet (2023) Vol. 401, Iss. 10384, pp. 1293-1301
Closed Access | Times Cited: 328
Paul M. Ridker, Deepak L. Bhatt, Aruna D. Pradhan, et al.
The Lancet (2023) Vol. 401, Iss. 10384, pp. 1293-1301
Closed Access | Times Cited: 328
Low-Dose Colchicine for Secondary Prevention of Coronary Artery Disease
Kyle A. Nelson, Valentı́n Fuster, Paul M. Ridker
Journal of the American College of Cardiology (2023) Vol. 82, Iss. 7, pp. 648-660
Closed Access | Times Cited: 106
Kyle A. Nelson, Valentı́n Fuster, Paul M. Ridker
Journal of the American College of Cardiology (2023) Vol. 82, Iss. 7, pp. 648-660
Closed Access | Times Cited: 106
Overview and New Insights into the Metabolic Syndrome: Risk Factors and Emerging Variables in the Development of Type 2 Diabetes and Cerebrocardiovascular Disease
Melvin R. Hayden
Medicina (2023) Vol. 59, Iss. 3, pp. 561-561
Open Access | Times Cited: 53
Melvin R. Hayden
Medicina (2023) Vol. 59, Iss. 3, pp. 561-561
Open Access | Times Cited: 53
Dyslipidemia and Cardiovascular Disease: Current Knowledge, Existing Challenges, and New Opportunities for Management Strategies
Zhiyong Du, Yanwen Qin
Journal of Clinical Medicine (2023) Vol. 12, Iss. 1, pp. 363-363
Open Access | Times Cited: 48
Zhiyong Du, Yanwen Qin
Journal of Clinical Medicine (2023) Vol. 12, Iss. 1, pp. 363-363
Open Access | Times Cited: 48
Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention
Daniel Tobias Michaeli, Julia Caroline Michaeli, Sebastian Albers, et al.
American Journal of Cardiovascular Drugs (2023) Vol. 23, Iss. 5, pp. 477-495
Open Access | Times Cited: 46
Daniel Tobias Michaeli, Julia Caroline Michaeli, Sebastian Albers, et al.
American Journal of Cardiovascular Drugs (2023) Vol. 23, Iss. 5, pp. 477-495
Open Access | Times Cited: 46
Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women
Paul M. Ridker, M. Vinayaga Moorthy, Nancy R. Cook, et al.
New England Journal of Medicine (2024)
Closed Access | Times Cited: 46
Paul M. Ridker, M. Vinayaga Moorthy, Nancy R. Cook, et al.
New England Journal of Medicine (2024)
Closed Access | Times Cited: 46
Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial
Miao Yu, Yong Yang, Silai Dong, et al.
Circulation (2024) Vol. 150, Iss. 13, pp. 981-993
Closed Access | Times Cited: 21
Miao Yu, Yong Yang, Silai Dong, et al.
Circulation (2024) Vol. 150, Iss. 13, pp. 981-993
Closed Access | Times Cited: 21
Advances in Dyslipidaemia Treatments: Focusing on ApoC3 and ANGPTL3 Inhibitors
Brian Tomlinson, Qianyan Wu, Yi-ming Zhong, et al.
Journal of Lipid and Atherosclerosis (2024) Vol. 13, Iss. 1, pp. 2-2
Open Access | Times Cited: 18
Brian Tomlinson, Qianyan Wu, Yi-ming Zhong, et al.
Journal of Lipid and Atherosclerosis (2024) Vol. 13, Iss. 1, pp. 2-2
Open Access | Times Cited: 18
High lipoprotein(a): Actionable strategies for risk assessment and mitigation
Gissette Reyes‐Soffer, Calvin Yeang, Erin D. Michos, et al.
American Journal of Preventive Cardiology (2024) Vol. 18, pp. 100651-100651
Open Access | Times Cited: 17
Gissette Reyes‐Soffer, Calvin Yeang, Erin D. Michos, et al.
American Journal of Preventive Cardiology (2024) Vol. 18, pp. 100651-100651
Open Access | Times Cited: 17
Insights Into Causal Effects of Genetically Proxied Lipids and Lipid‐Modifying Drug Targets on Cardiometabolic Diseases
Liwan Fu, Qin Liu, Hong Cheng, et al.
Journal of the American Heart Association (2025)
Open Access | Times Cited: 2
Liwan Fu, Qin Liu, Hong Cheng, et al.
Journal of the American Heart Association (2025)
Open Access | Times Cited: 2
Role of apolipoprotein C1 in lipoprotein metabolism, atherosclerosis and diabetes: a systematic review
Alexia Rouland, David Masson, Laurent Lagrost, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 51
Alexia Rouland, David Masson, Laurent Lagrost, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 51
APOC3 inhibition with volanesorsen reduces hepatic steatosis in patients with severe hypertriglyceridemia
Thomas A Prohaska, Veronica J. Alexander, Ewa Karwatowska‐Prokopczuk, et al.
Journal of clinical lipidology (2023) Vol. 17, Iss. 3, pp. 406-411
Open Access | Times Cited: 30
Thomas A Prohaska, Veronica J. Alexander, Ewa Karwatowska‐Prokopczuk, et al.
Journal of clinical lipidology (2023) Vol. 17, Iss. 3, pp. 406-411
Open Access | Times Cited: 30
MaiJiTong granule attenuates atherosclerosis by reducing ferroptosis via activating STAT6-mediated inhibition of DMT1 and SOCS1/p53 pathways in LDLR−/− mice
Jia Shi, Ming Ming Yang, Shu Yang, et al.
Phytomedicine (2024) Vol. 128, pp. 155489-155489
Closed Access | Times Cited: 12
Jia Shi, Ming Ming Yang, Shu Yang, et al.
Phytomedicine (2024) Vol. 128, pp. 155489-155489
Closed Access | Times Cited: 12
New approaches to triglyceride reduction: Is there any hope left?
Annalisa Filtz, Siddhant Parihar, G Greenberg, et al.
American Journal of Preventive Cardiology (2024) Vol. 18, pp. 100648-100648
Open Access | Times Cited: 9
Annalisa Filtz, Siddhant Parihar, G Greenberg, et al.
American Journal of Preventive Cardiology (2024) Vol. 18, pp. 100648-100648
Open Access | Times Cited: 9
Addressing residual risk beyond statin therapy: New targets in the management of dyslipidaemias–A report from the European Society of Cardiology Cardiovascular Round Table
François Mach, Frank L.J. Visseren, Nilo B. Cater, et al.
Journal of clinical lipidology (2024) Vol. 18, Iss. 5, pp. e685-e700
Closed Access | Times Cited: 9
François Mach, Frank L.J. Visseren, Nilo B. Cater, et al.
Journal of clinical lipidology (2024) Vol. 18, Iss. 5, pp. e685-e700
Closed Access | Times Cited: 9
Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis
Baihui Zhang, Fan Yin, Yanan Qiao, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 38
Baihui Zhang, Fan Yin, Yanan Qiao, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 38
Structural Elucidation and Activities of Cordyceps militaris-Derived Polysaccharides: A Review
Miao Miao, Wenqian Yu, Yuan Li, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 35
Miao Miao, Wenqian Yu, Yuan Li, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 35
Nanomaterials Responsive to Endogenous Biomarkers for Cardiovascular Disease Theranostics
Chuang Wei, Zeyu Jiang, Congcong Li, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 26
Closed Access | Times Cited: 21
Chuang Wei, Zeyu Jiang, Congcong Li, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 26
Closed Access | Times Cited: 21
Diagnostic and Therapeutic Aptamers
Vittoria Di Mauro, Francesca Cecilia Lauta, Jessica Modica, et al.
JACC Basic to Translational Science (2023) Vol. 9, Iss. 2, pp. 260-277
Open Access | Times Cited: 20
Vittoria Di Mauro, Francesca Cecilia Lauta, Jessica Modica, et al.
JACC Basic to Translational Science (2023) Vol. 9, Iss. 2, pp. 260-277
Open Access | Times Cited: 20
Overview and New Insights into the Metabolic Syndrome: Risk Factors and Emerging Variables in the Development of Type 2 Diabetes and Cerebrocardiovascular Disease
Melvin R. Hayden
(2023)
Open Access | Times Cited: 18
Melvin R. Hayden
(2023)
Open Access | Times Cited: 18
Lipoproteins, Cholesterol, and Atherosclerotic Cardiovascular Disease in East Asians and Europeans
Takahito Doi, Anne Langsted, Børge G. Nordestgaard
Journal of Atherosclerosis and Thrombosis (2023) Vol. 30, Iss. 11, pp. 1525-1546
Open Access | Times Cited: 17
Takahito Doi, Anne Langsted, Børge G. Nordestgaard
Journal of Atherosclerosis and Thrombosis (2023) Vol. 30, Iss. 11, pp. 1525-1546
Open Access | Times Cited: 17
Engineered exosomes as a prospective therapy for diabetic foot ulcers
Lifei Guo, Dan Xiao, Helin Xing, et al.
Burns & Trauma (2024) Vol. 12
Open Access | Times Cited: 8
Lifei Guo, Dan Xiao, Helin Xing, et al.
Burns & Trauma (2024) Vol. 12
Open Access | Times Cited: 8
Exploring the Molecular Mechanism of Schisandrin C for the Treatment of Atherosclerosis via the PI3K/AKT/mTOR Autophagy Pathway
Hong Duan, Han Li, Tianyi Liu, et al.
ACS Omega (2024)
Open Access | Times Cited: 6
Hong Duan, Han Li, Tianyi Liu, et al.
ACS Omega (2024)
Open Access | Times Cited: 6
Chasing LDL cholesterol to the bottom — PCSK9 in perspective
Peter Libby, Lâle Tokgözoğlu
Nature Cardiovascular Research (2022) Vol. 1, Iss. 6, pp. 554-561
Open Access | Times Cited: 27
Peter Libby, Lâle Tokgözoğlu
Nature Cardiovascular Research (2022) Vol. 1, Iss. 6, pp. 554-561
Open Access | Times Cited: 27
